Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: AcuCort AB

Market Cap 106M 11.04M 9.62M 8.91M 8.34M 15.65M 1.04B 15.74M 40.98M 513M 41.43M 40.54M 1.78B P/E 2024
-3.61x
P/E 2025 -5x
Enterprise Value 78.72M 8.22M 7.16M 6.64M 6.21M 11.65M 775M 11.72M 30.51M 382M 30.85M 30.18M 1.33B EV / Sales 2024
11.3x
EV / Sales 2025 17x
Free-Float
36.58%
Yield 2024 *
-
Yield 2025 -
1 day-32.69%
1 week-31.04%
Current month-34.64%
1 month-37.71%
3 months-22.11%
6 months-21.97%
Current year-24.83%
1 week 0.4
Extreme 0.401
0.67
1 month 0.4
Extreme 0.401
0.74
Current year 0.4
Extreme 0.401
0.95
1 year 0.4
Extreme 0.401
0.95
3 years 0.33
Extreme 0.327
1.45
5 years 0.33
Extreme 0.327
5.42
10 years 0.33
Extreme 0.327
9.5
Manager TitleAgeSince
Chief Executive Officer 55 08/08/2020
Corporate Officer/Principal 53 13/10/2025
Director TitleAgeSince
Director/Board Member 68 07/02/2017
Chairman 63 31/12/2017
Director/Board Member 79 31/12/2020
Change 5-day change 1-year change 3-year change Capi.($)
-32.69%-31.04%-39.05%-68.68% 11.04M
-3.48%-10.23%-14.66%-28.75% 14.31B
-0.61%-7.08%-24.60%-26.62% 6.81B
-0.13%-0.32%-20.64%-14.40% 5.69B
+0.61%-8.51%-15.43%-36.67% 3.56B
+3.24%+3.22%-32.90%-7.95% 3.45B
+0.05%+0.52%-22.41%-43.59% 3.32B
+0.50%-6.00%+1.25%-42.28% 2.72B
-2.28%-1.58%+111.00% - 2.69B
+3.90%+1.73%+7.70%+45.25% 1.77B
Average -3.09%-5.24%-4.97%-24.85% 4.43B
Weighted average by Cap. -0.89%-3.69%-9.54%-24.32%

Financials

2024 2025
Net sales 7.72M 806K 702K 651K 609K 1.14M 76.01M 1.15M 2.99M 37.41M 3.02M 2.96M 130M 6.68M 698K 608K 563K 527K 989K 65.83M 995K 2.59M 32.4M 2.62M 2.56M 113M
Net income -17.4M -1.82M -1.58M -1.47M -1.37M -2.57M -171M -2.59M -6.74M -84.35M -6.82M -6.67M -293M -26.19M -2.73M -2.38M -2.21M -2.07M -3.88M -258M -3.9M -10.15M -127M -10.26M -10.04M -441M
Net Debt -2.77M -289K -252K -234K -219K -410K -27.3M -413K -1.07M -13.44M -1.09M -1.06M -46.66M -27.01M -2.82M -2.46M -2.28M -2.13M -4M -266M -4.02M -10.47M -131M -10.58M -10.36M -455M
Logo AcuCort AB
AcuCort AB is a Sweden-based pharmaceutical company. The company develops oral films ISICORT, which involve chemical substance glucocorticoid dexamethasone that is used for the treatment of acute allergic reactions, as well as for nausea and vomiting during chemotherapy treatments. AcuCort AB operates mostly in Nordic countries.
Employees
5
Date Price Change Volume
18/06/26 0.4510 kr -32.69% 3,438,034
17/06/26 0.6700 kr +1.52% 99,648
16/06/26 0.6600 kr +2.17% 392,043
15/06/26 0.6460 kr -1.22% 453,817
  1. Stock Market
  2. Stocks
  3. ACUC Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!